← Back to Clinical Trials
Recruiting NCT06595628

NCT06595628 Modified Guarnieri-Desarda Technique Versus Lichtenstein Technique in Inguinal Hernia Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06595628
Status Recruiting
Phase
Sponsor Cairo University
Condition Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-10-10
Primary Completion 2025-10-01

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Lichtenstein Mesh-Based HernioplastyCombined Modified Guarnieri-Desarda Tissue-Based Hernioplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-10-10 with a primary completion date of 2025-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare the surgical outcome of both Lichnichtien tension free mesh hernioplasty of inguinal hernia and the combined modified Guarnieri Desarda technique in terms of postoperative pain, post operative complications (seroma, hematoma, wound infection), chronic inguinodenia, early recurrence and assessment of testicular vascularity and size by application of a testicular duplex and ultrasound.

Eligibility Criteria

Inclusion Criteria: * Adult male patients aged 18 years or older. * Patients diagnosed with non-complicated inguinal hernia (both direct and indirect). * Patients able to provide written informed consent to participate in the study. Exclusion Criteria: * Patients younger than 18 years old. * Patients with complicated hernias (e.g., inflamed, obstructed, or strangulated hernias). * Patients with a recurrent inguinal hernia. * Patients with weak or thin external oblique aponeurosis (intraoperative findings). * Patients with a history of prior surgery in the inguinal region. * Patients who refuse to participate in the study.

Contact & Investigator

Central Contact

Fadi F. Khalil, MSc

✉ fady.azmi37080@postgrad.kasralainy.edu.eg

📞 01285612963

Principal Investigator

Fadi F. Khalil, MSc

PRINCIPAL INVESTIGATOR

Kasr El Aini Hospital

Frequently Asked Questions

Who can join the NCT06595628 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06595628 currently recruiting?

Yes, NCT06595628 is actively recruiting participants. Contact the research team at fady.azmi37080@postgrad.kasralainy.edu.eg for enrollment information.

Where is the NCT06595628 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06595628 clinical trial?

NCT06595628 is sponsored by Cairo University. The principal investigator is Fadi F. Khalil, MSc at Kasr El Aini Hospital. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology